IN THE NEWS: Wonder drug?

Cancer Wellness

M. Najeeb Al Hallak, M.D., MS, member of the Gastrointestinal and Neuroendocrine Oncology and the Phase 1 Clinical Trials Multidisciplinary Teams at Karmanos, explains why a new immunotherapy drug called dostarlimab may be a treatment option for some colorectal cancer patients. He also comments on a recent trial where each participating patient is now cancer-free.

Read the article here.